Will MDR-1/P-gp modulators provide clinical benefit in hematologic malignancies?

Daruka Mahadevan

doi:10.1016/j.leukres.2006.03.014

Will MDR-1/P-gp modulators provide clinical benefit in hematologic malignancies?

Daruka Mahadevan

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1077-1078
Number of pages	2
Journal	Leukemia Research
Volume	30
Issue number	9
DOIs	https://doi.org/10.1016/j.leukres.2006.03.014
State	Published - Sep 2006
Externally published	Yes

Keywords

In hematologic malignancies
KT-5720
Multidrug resistance transporter-1
P-gp modulators

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.leukres.2006.03.014

Cite this

@article{caffd249ba7e4d188efea438c657b2db,

title = "Will MDR-1/P-gp modulators provide clinical benefit in hematologic malignancies?",

keywords = "In hematologic malignancies, KT-5720, Multidrug resistance transporter-1, P-gp modulators",

author = "Daruka Mahadevan",

year = "2006",

month = sep,

doi = "10.1016/j.leukres.2006.03.014",

language = "English (US)",

volume = "30",

pages = "1077--1078",

journal = "Leukemia Research",

issn = "0145-2126",